2025 War Room Performance So far in 2025, Karim and I are delivering – big time. Year to date, we've hit winners on 112 out of 148 total trades, which amounts to a +75% winning percentage – and an average return of +6.11% every 20 days. I'll take those numbers any day of the week and twice on Sunday. So, let's keep it rolling! One trade that I really happen to like right now is Amgen (AMGN). Alan Berro of American Funds tells Barron's this week that Amgen's Phase III GLP-1 drug will probably emerge as the #3 drug category in the weight-loss market, but Wall Street has yet to give it the credit that it deserves. The benefit of Amgen's drug is that a patient will only require a shot 4x per year, versus Lilly's drug that requires a shot every week. As a comparison, AMGN trades at 17x consensus P/E with a 3.5% dividend yield, while LLY yields less than 1% and trades at 33x consensus P/E. YOUR ACTION PLAN As I've been saying, AMGN has tremendous value right now – which is why I like adding it to your portfolio at current levels. If you've ever wondered what it's like to be part of our elite trading community, then I have some exciting news to share... You're invited to attend the premiere of our newest video titled... "Trade Where Millionaires Trade" Join a secret group of ultra-wealthy investors extracting up to $494,100.00 each day in the markets... Cash piles like these were already collected: - On August 20th, $118,932.00
- On September 9th, $212,047.00
- On September 11th, $174,369.00
- On September 26th, $484,000.00
- On November 4th, $494,100.00
Get an INSIDE LOOK at the most successful trading research community in existence today. Clear your schedule! "Trade Where Millionaires Trade" premieres on Wednesday, June 4th at 2:00 EST. RSVP Now! |
No comments:
Post a Comment